Delivery Order SPE2DR25D2014-SPE2DR26FA2C9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Depakote DR 500 mg tablets (100-count units) valued at $1,830.00. The contract was awarded on November 5, 2025, as a firm fixed-price delivery order with an ultimate completion date of November 6, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $1,506.66 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $3,092.44 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $2,622.00 to AmerisourceBergen Drug Corp for Depakote ER 250 mg tablets (100 count) on November 3, 2025, with a completion date of November 4, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,138.74 to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) on December 1, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by December 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Depakote DR 250 mg tablets (100-count units) with a ceiling value of $1,078.01. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's distribution...
- The Defense Logistics Agency awarded a delivery order valued at $9,442.36 to AmerisourceBergen Drug Corp for the supply of Depakote DR 125 mg Sprinkle Capsules (100-count) on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under the company's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $2,515.48 to AmerisourceBergen Drug Corp for the supply of Depakote DR 125 mg Sprinkle capsules (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Depakote ER 500 mg tablets (100-count units) with a ceiling value of $1,357.91. This is a firm fixed-price, non-set-aside delivery order contract with an ultimate completion date of September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,358.37 to AmerisourceBergen Drug Corp for 100 units of Depakote DR 125 mg Sprinkle capsules, with a completion deadline of July 21, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a direct procurement of pharmaceutical inventory to support federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2C9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,060.11 to AmerisourceBergen Drug Corp for 100 tablets of Depakote DR 250 mg on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a child entity under its parent company Cencora, Inc., which does business as AmerisourceBergen. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. Depakote DR is an anticonvulsant and mood stabilizer medication commonly used by military and federal healthcare systems for neurological and psychiatric conditions. The IDC enables AmerisourceBergen to supply an extensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs and other federal medical institutions worldwide, demonstrating the company's critical role in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/11/26 |